AGT and diabetic kidney disease: In an in vitro study using mouse podocytes damaged by angiotensin II—similar to what is found in DKD pathogenesis—exposure to melatonin attenuated ROS generation, resulting in less apoptosis and restoration of cell viability, among other protective effects (11).